宝济药业-B(02659.HK)拟实施H股全流通计划

Group 1 - The company announced that it has submitted filing materials to the China Securities Regulatory Commission for the implementation of full circulation of H-shares [1] - A total of 63.1163 million unlisted shares will be converted into H-shares, which represents approximately 19.36% of the company's total issued shares as of the announcement date [1]